Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Urology
Published in: BMC Urology 1/2020

Open Access 01-12-2020 | Benign Prostatic Hypertrophy | Research article

Preoperative predictors of enucleation time during en bloc ‘no-touch’ holmium laser enucleation of the prostate

Authors: Chun-Hsuan Lin, Wen-Jeng Wu, Ching-Chia Li, Sheng-Chen Wen

Published in: BMC Urology | Issue 1/2020

Login to get access

Abstract

Background

To evaluate preoperative predictors of enucleation time during en bloc ‘no-touch’ holmium laser enucleation of the prostate (HoLEP)

Methods

We enrolled 135 patients with symptomatic benign prostatic hyperplasia (BPH) treated with en bloc ‘no-touch’ HoLEP from July 2017 to March 2019 by a single surgeon. Preoperative, perioperative, and postoperative clinical variables were examined. Stepwise linear regression was performed to determine clinical variables associated with enucleation times.

Result

The average (range) enucleation time was 46.1 (12–220) minutes, and the overall operation time was 71 (18–250) minutes. History of antiplatelet agents, history of urinary tract infection (UTI), and increasing specimen weight were each significantly associated with increasing enucleation time. No category IV complications were recorded, and all complications were evenly distributed among the groups according to the HoLEP specimen weight.

Conclusion

En bloc ‘no-touch’ HoLEP was found to be an efficient and reproducible surgical method for treating BPH. Prostatic gland size was significantly associated with increased enucleation times. Similarly, history of UTI and antiplatelet agents were correlated with increased operative time.
Appendix
Available only for authorised users
Literature
1.
Gilling PJ, et al. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology. 1996;47:48–51.CrossRef
2.
Naspro R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up. Eur Urol. 2006;50:563–8.CrossRef
3.
Salonia A, et al. Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis. Urology. 2006;68:302–6.CrossRef
4.
Fraundorfer MR, Gilling PJ. Holmium: YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol. 1993;33:69–72.CrossRef
5.
Gilling PJ, et al. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109:408–11.CrossRef
6.
Cornu JN, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67:1066–96.CrossRef
7.
Kuntz RM, Lehrich K. Ahyai SA Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53:160–8.CrossRef
8.
Krambeck AE, Handa SE, Lingeman JE. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2013;189:S141–5.CrossRef
9.
Dusing MW, et al. Holmium laser enucleation of the prostate: efficiency gained by experience and operative technique. J Urol. 2010;184:635–40.CrossRef
10.
Vavassori I, et al. Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol. 2008;53:599–606.CrossRef
11.
Shah HN, et al. Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol. 2007;177:1468–74.CrossRef
12.
Arrighi HM, et al. Natural history of benign prostatichyperplasia and risk of prostatectomy: the Baltimore Longitudinal Study of Aging. Urology. 1991;38:4–8.CrossRef
13.
Committee APG. AUA guideline on management of benign prostatic hyperplasia. J Urol. 2003;170:530–47.CrossRef
14.
Tan A, et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003;170:1270–4.CrossRef
15.
Montorsi F, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2004;172:1926–9.CrossRef
16.
Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol. 2004a;18:189–91.CrossRef
17.
Kuntz RM, et al. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol. 2004;172:1012–6.CrossRef
18.
Scoffone CM, Cracco CM. The en-bloc no-touch holmium laser enucleation of the prostate (HoLEP) technique. World J Urol. 2016;34(8):1175–81.CrossRef
19.
Minagawa S, Okada S, Morikawa H. Safety and effectiveness of holmium laser enucleation of the prostate using a lowpower laser. Urology. 2017;110:51–5.CrossRef
20.
Kuo RL, Paterson RF, Kim SC, Siqueira TM Jr, Elhilali MM, Lingeman JE. Holmium laser enucleation of the prostate (HoLEP): a technical update. World J Surg Oncol. 2003;1(1):6.CrossRef
21.
Matlaga BR, et al. Holmium laser enucleation of the prostate for prostates of > 125 mL. BJU Int. 2006;97:81–4.CrossRef
22.
Monn MF, et al. Predictors of enucleation and morcellation time during holmium laser enucleation of the prostate. Urology. 2015;86:338–42.CrossRef
23.
Shah HN, et al. Influence of prostate size on the outcome of holmium laser enucleation of the prostate. BJU Int. 2008;101:1536–41.CrossRef
24.
Gandaglia G, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 2013;112:432–41.CrossRef
25.
Elzayat E, Habib E, Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol. 2006;175:1428–32.CrossRef
26.
Marks LS, et al. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J Urol. 1997;157:2171–8.CrossRef
27.
Marks LS, et al. Long-term effects of finasteride on prostate tissue composition. Urology. 1999;53:574–80.CrossRef
28.
Sandfeldt L, Bailey DM, Hahn RG. Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride. Urology. 2001;58:972–6.CrossRef
29.
Warner JN, et al. A multiinstitutional study of the effects of medical therapy for lower urinary symptoms on the perioperative outcomes of holmium laser enucleation of the prostate. Urology. 2011;78:1385–90.CrossRef
30.
Kuntz RM, Lehrich K, Ahyai S. Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size? J Endourol. 2004b;18:183–8.CrossRef
31.
Khae HK, et al. Enucleated weight/enucleation time, is it appropriate for estimating enucleation skills for holmium laser enucleation of the prostate? A consideration of energy consumption. World J Mens Health. 2018;36(1):79–86.CrossRef
Metadata
Title
Preoperative predictors of enucleation time during en bloc ‘no-touch’ holmium laser enucleation of the prostate
Authors
Chun-Hsuan Lin
Wen-Jeng Wu
Ching-Chia Li
Sheng-Chen Wen
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-00758-4

Other articles of this Issue 1/2020

BMC Urology 1/2020 Go to the issue

Case report

The left ureterocele and stone of calyceal diverticulum in the patient with bilateral incomplete duplex kidneys managed by flexible ureteroscopy: a case report and literature review

Research article

The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients

Case report

Small cell carcinoma of the bladder with coexisting prostate adenocarcinoma: two cases report and literature review

Correction

Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer Database

Case report

Myxoma of the renal pelvis masquerading pelviureteric stenosis: conservative limited resection with renal preservation: case presentation and literature review

Research article

Can clinical and urodynamic parameters predict the occurrence of neutralizing antibodies in therapy failure of intradetrusor onabotulinumtoxin A injections in patients with spinal cord injury?